
Aytu BioPharma, Inc.
NASDAQ:AYTU
1.25 (USD) • At close May 9, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Assets: | ||||||||||||||||||
Current Assets: | ||||||||||||||||||
Cash & Cash Equivalents
| 20.006 | 22.985 | 19.36 | 49.649 | 48.082 | 11.044 | 7.013 | 0.802 | 8.054 | 7.353 | 2.64 | 0.002 | 0 | 0.004 | 0.002 | 0.014 | 0.038 | 0.023 |
Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.041 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash and Short Term Investments
| 20.006 | 22.985 | 19.36 | 49.649 | 48.082 | 11.044 | 7.013 | 0.802 | 9.096 | 7.353 | 2.64 | 0.002 | 0 | 0.004 | 0.002 | 0.014 | 0.038 | 0.023 |
Net Receivables
| 23.617 | 28.937 | 21.712 | 28.176 | 5.633 | 1.741 | 0.579 | 0.528 | 0.162 | 0.157 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventory
| 12.633 | 11.995 | 10.849 | 16.339 | 9.999 | 1.44 | 1.339 | 1.312 | 0.525 | 0.039 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Assets
| 5.635 | 8.915 | 8.008 | 11.07 | 11.708 | 1.208 | 0.54 | 0.386 | 0.338 | 0.534 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Current Assets
| 61.891 | 72.832 | 59.929 | 105.234 | 74.966 | 15.433 | 9.47 | 3.029 | 10.12 | 8.084 | 3.302 | 0.002 | 0 | 0.004 | 0.002 | 0.014 | 0.038 | 0.023 |
Non-Current Assets: | ||||||||||||||||||
Property, Plant & Equipment, Net
| 1.522 | 3.869 | 6.296 | 8.703 | 0.893 | 0.204 | 0.219 | 0.647 | 0.231 | 0.03 | 0.057 | 0.008 | 0.012 | 0.019 | 0.025 | 0.028 | 0.036 | 0.036 |
Goodwill
| 0 | 0 | 0 | 65.802 | 28.09 | 0 | 0 | 0.238 | 0.221 | 0.074 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Intangible Assets
| 52.453 | 58.97 | 70.632 | 85.464 | 48.855 | 19.083 | 11.366 | 11.081 | 13.554 | 9.699 | 8.2 | 0.77 | 0 | 0 | 0 | 0 | 0 | 0 |
Goodwill and Intangible Assets
| 52.453 | 58.97 | 70.632 | 151.266 | 76.945 | 19.083 | 11.366 | 11.32 | 13.775 | 9.773 | 8.2 | 0.77 | 0 | 0 | 0 | 0 | 0 | 0 |
Long Term Investments
| 0 | -1.378 | 0 | -10.907 | -1.802 | 0 | 0 | 0 | 0 | -0.041 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tax Assets
| 0 | 1.378 | 0 | 10.907 | 1.802 | 0 | 0 | 0 | 0 | 0.041 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets
| 2.229 | 0.792 | 0.766 | 0.465 | 0.033 | 0.002 | 0.005 | 0.003 | 0.216 | 0.34 | 0.457 | -0.77 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Assets
| 56.204 | 63.631 | 77.694 | 160.434 | 77.871 | 19.289 | 11.59 | 11.97 | 14.223 | 10.143 | 8.714 | 0.008 | 0.012 | 0.019 | 0.025 | 0.028 | 0.036 | 0.036 |
Total Assets
| 118.095 | 136.463 | 137.623 | 265.668 | 152.836 | 34.721 | 21.06 | 14.999 | 24.343 | 18.227 | 12.016 | 0.01 | 0.013 | 0.023 | 0.027 | 0.042 | 0.074 | 0.06 |
Liabilities & Equity: | ||||||||||||||||||
Current Liabilities: | ||||||||||||||||||
Account Payables
| 10.44 | 13.478 | 10.987 | 19.255 | 11.64 | 2.134 | 2.12 | 2.22 | 2.323 | 1.195 | 0 | 0.007 | 0.006 | 0 | 0 | 0 | 0 | 0.002 |
Short Term Debt
| 4.252 | 0.085 | 3.909 | 24.704 | 1.282 | 0 | 0 | 0 | 0 | 0 | 0.031 | 0.1 | 0.068 | 0.052 | 0.078 | 0.055 | 0.048 | 0.034 |
Tax Payables
| 0 | 0 | 0 | 0 | 0.175 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue
| 0 | 46.799 | 0 | 57.234 | 0.339 | 0 | 0 | 0 | 0 | 0.086 | 0.086 | 0.264 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities
| 47.536 | 55.452 | 49.546 | 65.479 | 15.666 | 3.239 | 1.275 | 1.39 | 7.782 | 0.198 | 0.019 | 0.014 | 0.008 | 0.006 | 0.005 | 0.001 | 0 | 0.005 |
Total Current Liabilities
| 62.228 | 69.015 | 64.442 | 109.438 | 28.307 | 5.373 | 3.395 | 3.61 | 10.104 | 1.479 | 6.092 | 0.121 | 0.082 | 0.058 | 0.083 | 0.055 | 0.048 | 0.041 |
Non-Current Liabilities: | ||||||||||||||||||
Long Term Debt
| 10.877 | 14.713 | 14.279 | 5.428 | 0.725 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Revenue Non-Current
| 0 | -1.378 | 0 | -11.15 | -1.802 | 0 | 0 | 0 | 0 | 0.426 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Deferred Tax Liabilities Non-Current
| 0 | 1.378 | 0 | 11.15 | 1.802 | 0 | 0 | 0 | 0 | 0.041 | 0.043 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities
| 17.274 | 13.378 | 12.81 | 13.234 | 28.79 | 22.261 | 4.241 | 7.388 | 4.153 | 0.664 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total Non-Current Liabilities
| 28.151 | 28.091 | 27.089 | 18.662 | 29.514 | 22.261 | 4.241 | 7.388 | 4.153 | 1.131 | 0.554 | 0 | 0.074 | 0.053 | 0.078 | 0.055 | 0.048 | 0.036 |
Total Liabilities
| 90.379 | 97.106 | 91.531 | 128.1 | 57.821 | 27.634 | 7.636 | 10.999 | 14.258 | 2.61 | 6.647 | 0.121 | 0.082 | 0.058 | 0.083 | 0.055 | 0.048 | 0.041 |
Equity: | ||||||||||||||||||
Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Common Stock
| 0.001 | 0.001 | 0.004 | 0.003 | 0.013 | 0.002 | 0 | 0 | 0 | 0.001 | 0.001 | 0.414 | 0 | 0 | 0.001 | 0 | 0.205 | 0 |
Retained Earnings
| -319.973 | -304.129 | -288.472 | -178.299 | -120.01 | -106.39 | -79.258 | -69.07 | -46.561 | -18.381 | -10.658 | -0.569 | -0.001 | -0.001 | -0.001 | -0.254 | -0.196 | -0.139 |
Accumulated Other Comprehensive Income/Loss
| 0 | 0 | -0 | 0 | 0 | 0 | 0 | -0.246 | -0.112 | -5 | -0.033 | 10.472 | -0.511 | -0.451 | -0.314 | -0.001 | 0 | 0 |
Other Total Stockholders Equity
| 347.688 | 343.485 | 331.386 | 315.864 | 215.024 | 113.475 | 92.682 | 73.069 | 56.646 | 38.996 | 0.046 | 0.044 | -0.476 | 0.416 | 0.259 | -0.012 | 0.017 | 0.157 |
Total Shareholders Equity
| 27.716 | 39.357 | 46.092 | 137.568 | 95.015 | 7.088 | 13.425 | 4 | 10.085 | 15.616 | 5.369 | -0.111 | -0.07 | -0.036 | -0.056 | -0.014 | 0.026 | 0.019 |
Total Equity
| 27.716 | 39.357 | 46.092 | 137.568 | 95.015 | 7.088 | 13.425 | 4 | 10.085 | 15.616 | 5.369 | -0.111 | -0.07 | -0.036 | -0.056 | -0.014 | 0.026 | 0.019 |
Total Liabilities & Shareholders Equity
| 118.095 | 136.463 | 137.623 | 265.668 | 152.836 | 34.721 | 21.06 | 14.999 | 24.343 | 18.227 | 12.016 | 0.01 | 0.013 | 0.023 | 0.027 | 0.042 | 0.074 | 0.06 |